Physician profile
Charles Kind
NPI 1013657550
$620.95
in general payments reported to CMS, 2019-2025
8 companies · $621 in 2025
The $621 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $620.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $188.59 | 2025 | Grafix Pl, Versajet |
| Surgenex LLC | $131.93 | 2025 | Surgraft, Surmatrix, Pellograft |
| Bone Support INC. | $117.60 | 2025 | Cerament G, Ceramentbone Void Filler |
| Zimmer Biomet Holdings, INC. | $104.43 | 2025 | Zimmer Collagen Patch |
| Lightbody Medical Technologies INC | $29.72 | 2025 | |
| Treace Medical Concepts, INC. | $25.33 | 2025 | |
| Medline Industries LP | $15.52 | 2025 | |
| Biocomposites INC | $7.83 | 2025 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Kind listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.